JDD Podcast
Support the (On)cause: A Practical Review of Supportive Oncodermatology
Drs. Mario Lacouture and Adam Friedman
Cancer sucks, plain and simple. What is often overlooked is that the life saving/altering therapies often come with substantial baggage adding to this proclamation with skin, hair, and nail adverse events significantly impacting quality of life and even treatment course.
Enter supportive oncodermatology, and along with it the mastermind behind this rapidly emerging field, Dr. Mario Lacouture, Professor and Director of the Oncodermatology Program in the Dermatology Service, Department of Medicine, at Memorial Sloan Kettering Cancer Center in New York City.
Dr. Lacatoure joins podcast host Dr. Adam Friedman to discuss the array of cutaneous clusters that not only can, but are almost expected to occur during cancer therapy. Learn how even simple OTC products can contribute to both ameliorating and even preventing some of these sequelae. Understand how you (yeah, I’m talkin’ to you) can make an extraordinary impact in these patients’ lives. Tune in to this podcast to support your supportive oncoderm fund of knowledge.
This podcast was supported by Johnson & Johnson Consumer Inc.
Listen Now
Upcoming Related Supplement:
- The Biological Impact of Oats: Eczema and Beyond
- Blair Allais MD and Adam Friedman MD FAAD
- Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC
- October 2020 | Volume 19 | Issue 10 | Supplement| Copyright © October 2020
You May Also Like
iTunes Google Play Stitcher TuneIn Spotify Dr. Peter Lio “What should I buy, what should I use, do I need skin care?” Sound familiar? Whether it be a patient or…
iTunes Google Play Stitcher TuneIn Spotify Hosts: Dr. Adam Friedman and Dr. Steven Feldman Actions speak louder than words…so long as the words inspire, encourage, engage, etc. the actions. This…
iTunes Google Play Stitcher TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for you…
